Stay updated on Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was added. A large block of non-core footer and indexing terms was removed from the page, simplifying the display without changing the core study details.
    Difference
    18%
    Check dated 2026-08-08T18:14:26.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.6.4 was applied to the page. This is a back-end update and does not modify the study information, eligibility criteria, or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-07-25T11:33:26.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    39 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.2 to v3.6.3. This indicates a maintenance update to the page's underlying software rather than changes to study details.
    Difference
    0.1%
    Check dated 2026-07-03T23:50:24.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, signaling a routine maintenance update to the study page. No content changes to the study details or eligibility criteria are indicated by this revision.
    Difference
    0.1%
    Check dated 2026-06-26T23:11:31.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The study's recruitment status now indicates it is no longer looking for participants, signaling halted enrollment. New help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and a revision note (v3.6.0) with a formatting change to the Intervention/Treatment header was introduced.
    Difference
    0.6%
    Check dated 2026-06-12T16:28:27.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The revision tag on the page updated from v3.5.4 to v3.5.5. This indicates a minor page update rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-06-05T13:13:35.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Renal Medullary Carcinoma Clinical Trial page.